Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 125

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 125
---
 Statement. 

Item 13. Certain Relationships and Related Transactions, and Director Independence. 

Information required by this item is incorporated by reference to the information set forth in the sections titled “Information Regarding the Board of Directors and Corporate Governance – Independence of the Board of Directors” and “Transactions with Related Persons” in the Proxy Statement. 

Item 14. Principal Accounting Fees and Services. 

Information required by this item is incorporated by reference to the information set forth in the section titled “Independent Registered Public Accounting Firm Fees and Services” in the Proxy Statement.

141

PART IV 

Item 15. Exhibits and Financial Statement Schedules. 

(a)The following documents are filed as a part of this Annual Report:

(1)Consolidated Financial Statements:

Our Consolidated Financial Statements are listed in the “Index to Consolidated Financial Statements” under Part II, Item 8 of this Annual Report. 

(2)Financial Statement Schedules:

All financial statement schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes herein.

(3)Exhibits:

The documents listed in the following Exhibit Index of this Annual Report are incorporated by reference or are filed with this Annual Report on Form 10-K, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). 

142

Exhibit Index

    Incorporated by Reference

    ExhibitNumber
     
    Description
     
    ScheduleForm
     
    File Number
     
    Exhibit
     
    Filing Date

      3.1
     
    Articles of Continuance of Repare Therapeutics Inc. 
     
    8-K
     
    001-39335
     
    3.1
     
    June 23, 2020

      3.2
     
    Amended and Restated Bylaws of Repare Therapeutics Inc.
     
    8-K
     
    001-39335
     
    3.2
     
    June 23, 2020

      4.1
     
    Form of Common Share Certificate of the registrant.
     
    S-1
     
    333-238822
     
    4.1
     
    June 15, 2020

      4.2* 
     
    Warrant to Purchase Common Shares issued